(19)

(11)

EP 4 473 511 A1

(12)

(43) Date of publication: 11.12.2024 Bulletin 2024/50 (21) Application number: 23750313.1 (22) Date of filing: 26.01.2023

(51) International Patent Classification (IPC):  G07F 17/32(2006.01) G06N 20/20(2019.01) G06Q 50/34(2012.01) (52) Cooperative Patent Classification (CPC): G06Q 50/34; G07F 17/3288; G07F 17/3234; G07F 17/323; G06N 20/00; G06Q 30/0202 (86) International application number: PCT/US2023/061359 (87) International publication number: WO 2023/150464 (10.08.2023 Gazette 2023/32)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 04.02.2022 US 202217592725 (71) Applicant: ADRENALINEIP Washington, DC 20007 (US)	(72) Inventors: HUKE, Casey, Alexander Washington, DC 20007 (US) CRONIN, John Jericho, VT 05465 (US) BODKIN, Joseph Quincy, MA 02170 (US) GRANT, Harrison Anaheim, CA 92802 (US) (74) Representative: Araujo, Daniel  Ingenias Creaciones Signos e Invenciones S.L. Avda Diagonal 514 Planta 1, Puerta 4 08006 Barcelona 08006 Barcelona (ES)